The effects of endothelial dysfunction and inflammation on slow coronary flow

Turk Kardiyoloji Dernegi Arsivi

Volumn 38, Issue 5, 2010, Pages 327-333

  Ari, Hasan ^a   Ari, Selma ^a   Erdoǧan, Ercan ^a   Tiryakioǧlu, Osman ^a   Huysal, Kaǧan ^a   Koca, Vedat ^a   Bozat, Tahsin ^a  

^a Bursa Yüksek Yhtisas Education and Research Hospital   (Turkey)

Author keywords

Blood flow velocity; C reactive protein; Coronary angiography; Endothelium; N,N dimethylarginine; Vascular

Indexed keywords

C REACTIVE PROTEIN; GLYCERYL TRINITRATE; N(G),N(G) DIMETHYLARGININE;

ADULT; ARTERITIS; ARTERY DILATATION; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; RIGHT CORONARY ARTERY; SLOW CORONARY FLOW; STATISTICAL ANALYSIS;

ARGININE; BLOOD FLOW VELOCITY; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY VESSELS; DILATATION, PATHOLOGIC; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION; LOGISTIC MODELS; MALE; MIDDLE AGED; NO-REFLOW PHENOMENON;

EID: 79953287182     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Leiper J, Vallance P. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc Res 1999;43:542-8. (Pubitemid 29369253)
2. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, Imaizumi T. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 1999;99:1141-6. (Pubitemid 29120084)
3. Böger RH. The emerging role of asymmetric dimethyl-arginine as a novel cardiovascular risk factor. Cardiovasc Res 2003;59:824-33. (Pubitemid 38366238)
4. Li JJ, Qin XW, Li ZC, Zeng HS, Gao Z, Xu B, et al. Increased plasma C-reactive protein and interleukin-6 concentrations in patients with slow coronary flow. Clin Chim Acta 2007;385:43-7. (Pubitemid 47374665)
5. Mangieri E, Macchiarelli G, Ciavolella M, Barillà F, Avella A, Martinotti A, et al. Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn 1996;37:375-81. (Pubitemid 26100780)
6. Cin VG, Pekdemir H, Camsar A, Çiçek D, Akkuş MN, Parmaksiz T, et al. Diffuse intimal thickening of coronary arteries in slow coronary flow. Jpn Heart J 2003; 44:907-19. (Pubitemid 41518947)
7. Sezgin AT, Sigirci A, Barutçu I, Topal E, Sezgin N, Özdemir R, et al. Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis 2003;14:155-61. (Pubitemid 36543418)
8. Riza Erbay A, Turhan H, Yaşar AS, Ayaz S, Şahin O, Şenen K, et al. Elevated level of plasma homocysteine in patients with slow coronary flow. Int J Cardiol 2005; 102:419-23. (Pubitemid 40956902)
9. Yazici M, Balci B, Demircan S, Yeşildaǧ O, Saǧkan O, Şahin M, et al. Relationship between plasma endothelin- 1 levels and corrected TIMI frame count in patients with slow coronary artery flow. [Article in Turkish] Türk Kardiyol Dern Arş 2002;30:466-72.
10. Özyol A, Yilmaz MB. Coronary flow reserve and fractional flow reserve. [Article in Turkish] Türk Kardiyol Dern Arş 2007;35:253-61.
11. Dönmez Y, Kanadaşi M, Usal A, Zeren H. Slow coronary flow may be a sign of diffuse atherosclerosis: contribution of FFR and IVUS. Türk Kardiyol Dern Arş 2003;31:270-8.
12. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996;93:879-88. (Pubitemid 26074824)
13. Schulze F, Wesemann R, Schwedhelm E, Sydow K, Albsmeier J, Cooke JP, et al. Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay. Clin Chem Lab Med 2004;42:1377-83. (Pubitemid 40057825)
14. Pohl U, Busse R. Endothelium-dependent modulation of vascular tone and platelet function. Eur Heart J 1990; 11 Suppl B:35-42. (Pubitemid 20181248)
15. Parent R, Paré R, Lavallée M. Contribution of nitric oxide to dilation of resistance coronary vessels in conscious dogs. Am J Physiol 1992;262(1 Pt 2):H10-6.
16. Diaz MN, Frei B, Vita JA, Keaney JF Jr. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997; 337:408-16. (Pubitemid 27328371)
17. Cooke JP. Asymmetrical dimethylarginine: the Uber marker? Circulation 2004;109:1813-8.
18. Tousoulis D, Tentolouris C, Crake T, Toutouzas P, Davies G. Basal and flow-mediated nitric oxide production by atheromatous coronary arteries. J Am Coll Cardiol 1997;29:1256-62. (Pubitemid 27201943)
19. Reddy KG, Nair RN, Sheehan HM, Hodgson JM. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol 1994;23:833-43.
20. Lefroy DC, Crake T, Uren NG, Davies GJ, Maseri A. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation 1993;88:43-54. (Pubitemid 23195431)
21. Quyyumi AA, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM, et al. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J Clin Invest 1995;95:1747-55.
22. Selçuk MT, Selçuk H, Temizhan A, Maden O, Ulupinar H, Baysal E, et al. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow. Coron Artery Dis 2007;18:545-51. (Pubitemid 47556386)
23. Camsarl A, Pekdemir H, Çicek D, Polat G, Akkuş MN, Döven O, et al. Endothelin-1 and nitric oxide concentrations and their response to exercise in patients with slow coronary flow. Circ J 2003;67:1022-8. (Pubitemid 37493711)
24. Barutçu I, Sezgin AT, Sezgin N, Güllü H, Esen AM, Topal E, et al. Elevated plasma homocysteine level in slow coronary flow. Int J Cardiol 2005;101:143-5. (Pubitemid 40614751)
25. Turhan H, Saydam GS, Erbay AR, Ayaz S, Yaşar AS, Aksoy Y, et al. Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow. Int J Cardiol 2006; 108:224-30. (Pubitemid 43330618)
26. Yazici M, Aksakal E, Demircan S, Şahin M, Saǧkan O. Koroner yavaş akim inflamasyonla ve prokoagülan durumla ilişkili midir? Anadolu Kardiyol Derg 2005;5:3-7.
27. Roberts WC, Jones AA. Quantitation of coronary arterial narrowing at necropsy in sudden coronary death: analysis of 31 patients and comparison with 25 control subjects. Am J Cardiol 1979;44:39-45. (Pubitemid 9216890)
28. Abaci A, Oǧuzhan A, Eryol NK, Ergin A. Effect of potential confounding factors on the thrombolysis in myocardial infarction (TIMI) trial frame count and its reproducibility. Circulation 1999;100:2219-23.